Health Canada’s new drug licensing proposal contains no mechanism for making fast-tracked medicines affordable. THE CANADIAN PRESS/Ryan Remiorz June 26, 2023 Canada’s misguided changes to drug regulation could fast‑track unproven medications and divert funds from other health needs Steven G. Morgan, University of British Columbia; Aidan Hollis, University of Calgary; Christopher McCabe, Queen's University Belfast; Matthew Herder, Dalhousie University, and Mike Paulden, University of Alberta The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.
